摘要
国医大师刘嘉湘教授从20世纪60年代起开展中医药治疗恶性肿瘤的临床研究,注重受试者的生存期、生活质量和用药权益,强调中医药临床研究的科学性、规范性和伦理性。系统阐述刘教授近60年以来在中医药临床研究中倡导、实践和推动医学伦理的举措,并介绍其严谨的临床研究医学伦理素养,为国内外中医药临床研究的实施和受试者的保护提供宝贵的经验。
Professor Liu Jiaxiang,as one of the national traditional Chinese medicine(TCM)masters,has been conducting clinical research on the treatment of malignant tumors with TCM since the 1960s,focusing on the survival,quality of life,and rights and interests of subjects with medications,and emphasizing the scientific,normative and ethical aspects of clinical research in TCM.In this paper,we systematically describe Professor Liu’s initiatives in advocating,practicing and promoting medical ethics in TCM clinical research for nearly 60 years,and introduce his rigorous approach to medical ethics in clinical research,for the purpose of providing valuable experience for the implementation of TCM clinical research and the protection of subjects worldwide.
作者
姜怡
陈晓云
刘嘉湘
JIANG Yi;CHEN Xiaoyun;LIU Jiaxiang(Department of Oncology,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China;Department of Ethics,Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 200032,China)
出处
《上海中医药杂志》
CSCD
2023年第5期51-53,共3页
Shanghai Journal of Traditional Chinese Medicine
基金
国家中医药管理局第七批全国老中医药专家学术经验继承项目(2022)
上海市科委上海市中医肿瘤临床医学研究中心建设项目(21MC1930500)
上海市卫健委政策研究课题(2022HP82)
上海市卫健委上海市临床重点专科建设项目(shslczdzk03701)
上海市卫健委面上项目(202140370)。
关键词
医学伦理
临床研究
循证医学
中医药疗法
肿瘤
medical ethics
clinical research
evidence-based medicine
traditional Chinese medicine therapy
tumor